Sensitive

Alzheimer's disease

APOE · rs405509

Where this position leads

Condition: Alzheimer's Disease

Drug: Lecanemab and other anti-amyloid antibodies

rs405509 Condition: Alzheimer's Disease Alzheimer's Disease Condition Drug: Lecanemab and other anti-amyloid antibodies Lecanemab and other anti-amyloid an… Drug rs405509 rs405509 APOE

What the study found

Who was studied 952 European ancestry male cases, 1,789 European ancestry female cases, 6,337 European ancestry male controls, 8,402 European ancestry female controls.

The effect Each copy of the T allele carried 1.61 times the odds of Alzheimer's disease (95% confidence interval 1.46-1.77); p = 2 × 10−21.

How common The T allele had a frequency of about 50% in the people studied.

Where it sits Chromosome 19, band 19q13.32 — in a regulatory region of APOE.

What ClinVar records

Classification drug response for Warfarin response; no assertion criteria provided (0 of 4 stars, 1 submitter), last evaluated 2010-08-31. ClinVar record 619951 NC_000019.10:g.44905579T>G

Classification risk factor for Coronary artery disease, severe, susceptibility to; no assertion criteria provided (0 of 4 stars, 1 submitter), last evaluated 2003-06-01. ClinVar record 17877 NC_000019.10:g.44905579=

What this is ClinVar's aggregate record for this position (as of its 2026-10-12 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

What each result means

G/G No copy of the version the research linked to Alzheimer's disease. This is the starting point the study compared everyone against.
G/T One copy of the version the research linked to Alzheimer's disease. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Alzheimer's disease. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Questions about rs405509

What is rs405509?

rs405509 is a single position in the genome, in or near the APOE gene. Published research associates it with alzheimer's disease. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs405509 linked to?

On MyGeneLog this position is linked to Alzheimer's Disease. The research behind each link, and its sources, are set out on that condition page.

Does rs405509 affect how medicines work?

APOE carries pharmacogenomic findings for Lecanemab and other anti-amyloid antibodies. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.

Does having rs405509 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs405509 come from?

GWAS Catalog, Alzheimers Res Ther 2019, PMID:30636644. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Alzheimer's disease (rs405509). MyGeneLog™. https://www.mygenelog.com/variants/rs405509

← See all variants